Navigation Links
Diabetes drug could hold promise for lung cancer patients
Date:1/29/2013

f an issue for most cancer patients. The issue of kidney toxicity would also be bypassed in cancer patients because the course of treatment is much shorter, measured in weeks to months compared to years of treatment for diabetes patients.

The next step is to determine if phenformin alone would be a sufficient therapy for certain subsets of NSCLC or if the drug would perform better in combination with existing cancer drugs. Based on their findings, the researchers say that phenformin would be most useful in treating early-stage LKB1-mutant NSCLC, as an adjuvant therapy following surgical removal of a tumor, or in combination with other therapeutics for advanced tumors.

"The good news," says Shackelford, "is that our work provides a basis to initiate human studies. If we can organize enough clinicians who believe in investigating phenforminand many dothen phenformin as an anti-cancer agent could be a reality in the next several years."


'/>"/>
Contact: Andy Hoang
AHoang@salk.edu
619-861-5811
Salk Institute
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. How a cancer drug leads to diabetes
2. Heart failure patients with diabetes may benefit from higher glucose levels
3. Disrupted Sleep May Raise Risk for Obesity, Diabetes: Study
4. Mouse Study Hints at New Path for Diabetes Treatment
5. Common Plastics Chemical Might Boost Diabetes Risk
6. Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
7. Naturopathic care can improve blood sugar, mood in diabetes
8. Cellular pathway linked to diabetes, heart disease
9. Diabetes Groups Issue New Guidelines on Blood Sugar
10. Value of Metformin, Insulin Combo for Type 2 Diabetes Questioned
11. Xenotransplantation as a therapy for type 1 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Diabetes drug could hold promise for lung cancer patients
(Date:9/2/2015)... MA (PRWEB) , ... September 02, 2015 , ... ... get swamped with a large stream of mixed documents that include EOBs, payments, ... various documents, while extracting the data needed to reconcile their billing, with one ...
(Date:9/2/2015)... ... September 02, 2015 , ... Michael Elliot Media announces a crowdfunding campaign ... as the primary love interest in the film. The campaign is being called ... how and what we think,” Michael Elliot, an award-winning screenwriter and CEO of Michael ...
(Date:9/2/2015)... ... September 02, 2015 , ... Since 2011, DoMyOwnPestControl.com has been ... to help support childhood cancer research. On June 17, 2014, the owners of ... which is the fund-raising event DoMyOwnPestControl.com sponsors each year. The very next day ...
(Date:9/2/2015)... ... ... Every year at this time, students prepare to go back to school. ... the academic workload confronting them. They just don’t have the skills needed to do ... students how to study. , “Bankers bank. Salesmen sell. Teachers teach. The job of ...
(Date:9/2/2015)... IL (PRWEB) , ... September 02, 2015 , ... ... of patented products, announces Hand Free Pocket Cop, a safety invention that protects ... the US is worth $31 billion," says Scott Cooper, CEO and Creative Director ...
Breaking Medicine News(10 mins):Health News:AliusDoc Launches Enhanced AD-EOB A/R Data Capture Solution to Streamline Processing of Payment-Related Documents Together with EOBs 2Health News:Award-Winning Screenwriter Uses Crowdfunding Campaign to Change Hollywood’s Ideal of Beauty to Include PLUS-SIZE Women 2Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7
... KNOXVILLE, Tenn.--Provectus Pharmaceuticals, Inc. (OTCBB: PVCT) announced preliminary results ... the treatment of metastatic melanoma, the most aggressive form ... efficacy and bystander effect on melanoma tumors in stage ... Provecta in a total of 20 subjects at two ...
... infectious diseases and developing preventive vaccines is the ability ... response over time. An Emory-led team of scientists has ... are able to evade the immune response. The ... of the National Academy of Sciences. , Using a ...
... (TB) experts at Johns Hopkins and in Brazil have ... of drugs used to treat the highly contagious form ... to cure the illness from six months to four. ... antibiotics increased by 17 percent the number of patients ...
... survey [1] analysing how cancer research is funded ,shows ... contributor to the global ,cancer research effort. , Prof ... Forum (ECRM), launched the organisations second survey, which looks ... 2004, at the European Parliament today (Tuesday 18 September). ...
... a Year, TAMPA, Fla., Sept. 18 In response ... a two-week coma with a craving for The,Melting Pot, the ... The Melting Pot will fly Jill Finley and her family ... at its annual,meeting. On May 26, Finley,s husband Ryan ...
... College of Medicine of Yeshiva University has been awarded a ... of Health to further the medical schools study of centenarians ... Nir Barzilai, director of Einsteins Institute for Aging Research, the ... genes that appear to contribute to exceptional longevity in humans, ...
Cached Medicine News:Health News:Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study 2Health News:Chronic infection persists by targeting stromal cell network in lymphoid organs 2Health News:New antibiotic drug combo to speed up treatment of tuberculosis 2Health News:New antibiotic drug combo to speed up treatment of tuberculosis 3Health News:New antibiotic drug combo to speed up treatment of tuberculosis 4Health News:Launch of second European Cancer Research Funding survey 2Health News:Launch of second European Cancer Research Funding survey 3Health News:Launch of second European Cancer Research Funding survey 4Health News:Update on Jill Finley Story, Coma Survivor 2Health News:NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity 2
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cnq7tc/medical_device ) ... Device Studies: Clinical Evidence (London, UK - November ... This course has been designed specifically ... evidence required for medical devices and in-vitro diagnostic ... devices and the emphasis on high quality, appropriate ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurocrine Biosciences, Inc. ... Coughlin , Chief Financial Officer of Neurocrine Biosciences, will ... New York City . ... at 11:25am ET (8:25am PT).  The presentation will be ... at http://www.neurocrine.com .   Listeners are ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/r6wspz/drug_delivery_in ) has ... "Drug Delivery in Central Nervous System Diseases ... offering. Advances in understanding of ... new avenues and possibilities for improved drug delivery ... enzymes, and receptors that control the penetration of ...
Breaking Medicine Technology:Medical Device Studies: Clinical Evidence Course - London, UK - November 10-11, 2015 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 3
... PSTX) today announced that The Mount Sinai Hospital in New York City has implemented its Safety-Sponge System. , ... , , ... ... ...
... N.J. , March 15 Regado Biosciences, Inc., ... with active control agents, announced that Chris Rusconi , ... Zelenkofske , DO, FACC, Senior Vice President , Chief Medical ... on Monday, March 15, 2010 in Atlanta, ...
Cached Medicine Technology:Patient Safety Technologies, Inc., Contracts to Implement the Safety-Sponge(TM) System at The Mount Sinai Hospital in New York 2Patient Safety Technologies, Inc., Contracts to Implement the Safety-Sponge(TM) System at The Mount Sinai Hospital in New York 3Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 2Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 3Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 4
... basic portable system for pH and temperature ... obtained when used with a temperature probe ... and easy one- and two-point calibration with ... (pH 1.68, 4.00, 7.00, 10.01 and 12.45) ...
... 3 swing doors, 12 shelves. Over-sized compressor. ... Fluorescent interior lighting. Self-Contained System No plumbing ... Full One Year Warranty on Parts & ... Compressor. Also available as a chromatography ...
... 2 slide doors, 8 shelves. Over-sized ... doors. Fluorescent interior lighting. Self-Contained System ... foot cord. Full One Year Warranty on ... Warranty on Compressor. Also available as ...
... Independent controls for Digital ... series stainless steel front. Anodized aluminum ends. ... series stainless steel floor. , Oversized ... to -30C , Positive seal self-closing ...
Medicine Products: